Nathan Bryson
Technik-/Wissenschafts-/F&E-Leiter bei Reunion Neuroscience, Inc.
Profil
Nathan Bryson is the founder of Flamel Technologies SA, which was founded in 1990.
He is currently the Chief Scientific Officer at Reunion Neuroscience, Inc. since 2022.
He was also the Chief Science Officer at Field Trip Health Ltd.
from 2020 to 2022.
Dr. Bryson received his undergraduate degree from Auburn University in 1984 and his doctorate from Massachusetts Institute of Technology in 1988.
Aktive Positionen von Nathan Bryson
| Unternehmen | Position | Beginn |
|---|---|---|
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2022 |
Ehemalige bekannte Positionen von Nathan Bryson
| Unternehmen | Position | Ende |
|---|---|---|
| REUNION NEUROSCIENCE | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2022 |
| ACERUS PHARMACEUTICALS CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 06.03.2020 |
| CYNAPSUS THERAPEUTICS INC | Technik-/Wissenschafts-/F&E-Leiter | 22.01.2014 |
Bionisis SA
 Bionisis SA Medical SpecialtiesHealth Technology Bionisis SA distributes spearation instruments. The firm markets sorbent beds and accessories based on its patented OPLC technology(Optimum Performance Laminar ChromatographyTM). The firm provides solutions to chemists in the fields of organic synthesis, natural products, medicinal chemistry, drug discovery, lead optimization, toxicology, drug metabolism, forensic science, analytical development, chemical process R&D and manufacturing & quality control. The company was founded in 1999 and is headquartered in Le Plessis-Robinson, France | Technik-/Wissenschafts-/F&E-Leiter | 02.12.2008 |
Matregen Corp.
 Matregen Corp. Miscellaneous Commercial ServicesCommercial Services Matregen Corp. engaged in the development and commercialization of novel Drug Delivery Systems. Its SpinFX technology is a technique used to produce novel structures such as porous tubes, composites, and coatings. The company was founded by Dr. Molly S. Shoichet and Dr. Paul D. Dalton in 2002 and is headquartered in Toronto, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 |
Ausbildung von Nathan Bryson
| Auburn University | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
 | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
Cynapsus Therapeutics, Inc.
 Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada. | Health Technology |
Bionisis SA
Bionisis SA Medical SpecialtiesHealth Technology Bionisis SA distributes spearation instruments. The firm markets sorbent beds and accessories based on its patented OPLC technology(Optimum Performance Laminar ChromatographyTM). The firm provides solutions to chemists in the fields of organic synthesis, natural products, medicinal chemistry, drug discovery, lead optimization, toxicology, drug metabolism, forensic science, analytical development, chemical process R&D and manufacturing & quality control. The company was founded in 1999 and is headquartered in Le Plessis-Robinson, France | Health Technology |
Matregen Corp.
Matregen Corp. Miscellaneous Commercial ServicesCommercial Services Matregen Corp. engaged in the development and commercialization of novel Drug Delivery Systems. Its SpinFX technology is a technique used to produce novel structures such as porous tubes, composites, and coatings. The company was founded by Dr. Molly S. Shoichet and Dr. Paul D. Dalton in 2002 and is headquartered in Toronto, Canada. | Commercial Services |
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
Field Trip Health Ltd.
 Field Trip Health Ltd. Medical/Nursing ServicesHealth Services Field Trip Health Ltd. engages in development and delivery of technology-enabled psychedelic therapies. It offers psychedelic-enhanced and psychedelic-integration psychotherapy. The firm is developing patient-centric and evidence-based psychedelic approaches to behavioral and mental health. The company was founded by Joseph del Moral, Ronan Levy, Hannan Fleiman, Syed Mujeeb Jafferi, and Ryan Yermus on September 30, 2008 and is headquartered in Toronto, Canada. | Health Services |
